Analysis
View More
Download our latest Newsletter
Themes
View MoreObvioHealth Q&A: connecting DCT dots with remote tech
The move towards decentralised clinical trials has been accelerated by Covid-19, and the tech that underpins remote trials is evolving…
More themes
Thematic Buyer's Guides
View More
GlobalData Reports
View More
There aren't available reports.
Insights
View MoreA practical framework for choosing e-signatures in global trials
Ask a clinical trial sponsor when to use a qualified e-signature (QES) instead of a standard e-signature (AES), and you'll usually get one of two answers: “Wherever it's mandated” or…
More insights
Digital Magazine
View More
MINE Magazine
MINE Magazine is free to read on all devices including mobile and iPad. You can read the latest issue here or browse the archive for back issues. Subscribe to MINE Magazine and never miss an issue.
Comment
View MoreA practical framework for choosing e-signatures in global trials
Ask a clinical trial sponsor when to use a qualified e-signature (QES) instead of a standard e-signature (AES), and you'll usually get one of two answers: “Wherever it's mandated” or…
Sustaining long-term follow-up in cell and gene therapies
How RWD is shaping the next era of healthcare decision-making
AI in clinical trial finance
Why psychiatry needs better patient outcome data on medical cannabis